acousia Therapeutics GmbH
Sindelfinger Straße 3
Tübingen
72070
Germany
Website: http://www.acousia.com/
Email: info@acousia.com
About acousia Therapeutics GmbH
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has the expertise to identify small molecules for treatment of hearing loss.Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells.
LEADERSHIP:
CEO: Hubert Löwenheim
3 articles about acousia Therapeutics GmbH
-
Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
10/9/2023
Acousia Therapeutics received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ACOU085 in patients with cisplatin-induced hearing loss.
-
BioSpace Movers & Shakers, Nov. 6
11/6/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
acousia Therapeutics Receives EUR 2.5 Million To Develop Innovative Therapy To Treat And Prevent Sensorineural Hearing Loss
12/14/2016